SCHEMBL25146223

SCHEMBL25146223

COc1ccc(C(C)(C)C)c2ccn(C)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CYP19A1 P11511 4/20 0.33
▸ NQO2 P16083 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ RARA P10276 2/20 0.31
▸ RARB P10826 2/20 0.31
▸ RARG P13631 2/20 0.31
▸ PRMT1 Q99873 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ PRKACG P22612 1/20 0.31
▸ PRKACB P22694 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24981009 0.77 CYP19A1 (0.44) LMNAHPGDCYP19A1NQO2MAPT
SCHEMBL24981834 0.75 NQO2 (0.35) LMNACYP19A1NQO2MAPTCYP2C9
SCHEMBL24981671 0.75 CYP19A1 (0.34) LMNACYP19A1NQO2MAPTCYP2C9
SCHEMBL24981842 0.75 F2RL1 (0.40) LMNACYP19A1NQO2MAPTCYP2C9
SCHEMBL14886437 0.70 MAPT (0.46) HPGDMAPTCYP2C9ALDH1A1GAA
SCHEMBL15987332 0.69 NR4A2 (0.42) LMNAHPGDMAPTALDH1A1GAA
SCHEMBL8253573 0.68 IDO1 (0.53) LMNAHPGDMAPTALDH1A1KMT2A
SCHEMBL6030234 0.68 PRMT1 (0.36) LMNACYP19A1NQO2MAPTCYP2C9
SCHEMBL2949842 0.66 LMNA (0.43) LMNATP53CYP3A4HPGDALOX15
SCHEMBL21718524 0.66 LMNA (0.42) LMNATP53CYP3A4HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807635-B2 Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2023-11-07 — — US disclosed
US-11807635-B2 Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2023-11-07 — — US disclosed
US-20230121807-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF HAISCO PHARMACEUTICALS PTE. LTD (SG) 2023-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807635-B2 Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof DPP4, DPP3, DPP9 LMNA 4224/4885TP53 3438/4885CYP3A4 407/4885
US-20230121807-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF DPP4, DPP3, DPP9 LMNA 4224/4885TP53 3438/4885CYP3A4 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback